This book is more than just a compilation of nanomaterials used for the treatment and prevention of infectious diseases. It starts by tracing the historical trajectory of the nanomedicine field, charting its evolution to the present day.
This book is more than just a compilation of nanomaterials used for the treatment and prevention of infectious diseases. It starts by tracing the historical trajectory of the nanomedicine field, charting its evolution to the present day.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Íris Luz Batalha is currently a junior leader research fellow at the Institute for Bioengineering of Catalonia (IBEC) in Barcelona, a course director in nanotherapeutics at the University of Cambridge Institute of Continuing Education, a freelance senior innovation strategy consultant, a co-founder and director of the non-profit organization Women Ahead of Their Time (WATT), and a research associate at Peterhouse College. From 2017 to 2020, she was a joint research associate at the Department of Engineering Nanoscience Centre and Department of Medicine Molecular Immunity Unit, University of Cambridge. From 2014 to 2017, she worked at the Department of Chemical Engineering and Biotechnology, University of Cambridge, and the biopharmaceutical company MedImmune/AstraZeneca, followed by a brief experience as a healthcare/pharmaceutical competitive intelligence consultant. Her research interests and expertise lie in medical and pharmaceutical research and development, particularly in the fields of nanobiotechnology, bioinspired materials, downstream processing, formulation, and drug delivery.
Inhaltsangabe
1. Nanomedicine: A Historical Perspective 2. Clinically Approved Nanotherapeutics 3. High-Priority Pathogens: Where Do We Stand? 4. Overview of Nanotherapeutics for Viral Infections 5. Formulation Approaches for COVID-19 Vaccines 6. Overview of Nanotherapeutics for Bacterial Infections 7. Nanotechnology Applied to Tackle Malaria 8. Overview of Nanotherapeutics for Fungal Infections 9. Biogenic and Biomimetic Nanocarriers
1. Nanomedicine: A Historical Perspective 2. Clinically Approved Nanotherapeutics 3. High-Priority Pathogens: Where Do We Stand? 4. Overview of Nanotherapeutics for Viral Infections 5. Formulation Approaches for COVID-19 Vaccines 6. Overview of Nanotherapeutics for Bacterial Infections 7. Nanotechnology Applied to Tackle Malaria 8. Overview of Nanotherapeutics for Fungal Infections 9. Biogenic and Biomimetic Nanocarriers
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826